What is US20100160340A1 on Google Patents, and how does it relate to abemaciclib?
US20100160340A1 is a patent publication identified by its US publication number. Google Patents pages are indexed by publication number, and the title/claims determine whether it is about abemaciclib or about a different compound or technology.
With only “US20100160340A1 google patents abemaciclib” provided, I can’t reliably determine what the specific document covers (for example: whether it is directly about abemaciclib, a method for making a CDK inhibitor, a related scaffold, or a completely unrelated patent that just shares a similar search term). The abemaciclib connection depends on the actual title and claim wording shown on the Google Patents page.
If you paste the Google Patents title and/or the first independent claim (Claim 1), I can tell you precisely whether it is abemaciclib-specific, a generic CDK4/6 inhibitor patent that might include abemaciclib, or something else.
How to quickly verify the abemaciclib link on Google Patents
On the Google Patents page for the publication number, check these fields:
- Title: does it mention abemaciclib (or its chemical name) or CDK4/6 inhibition?
- Abstract and independent claims: look for abemaciclib by name, synonyms, or structure-defining language.
- Search within the page for “abemaciclib”: if Google’s on-page search shows it in claims/description, that’s a strong indicator of relevance.
- Assignee/applicant: if it’s tied to companies involved in abemaciclib’s development, that also helps confirm relevance.
If you share what you see in those areas, I’ll interpret it and summarize the scope.
Is this likely a patent about abemaciclib itself or broader CDK4/6 chemistry?
Most searches that combine a patent publication number and “abemaciclib” end up in one of these categories:
- Abemaciclib composition/method claims (direct coverage for the drug or specific uses)
- Related analogs or chemical classes that could encompass abemaciclib under broad Markush/functional language
- Methods of treatment using CDK4/6 inhibition where abemaciclib could be one of the contemplated agents
- Completely different subject matter where “abemaciclib” appears only as incidental background text (or not at all)
Determining which category applies requires reading the document’s claims/abstract.
If you want patentability or infringement-relevance: what matters most
For practical use (e.g., freedom-to-operate searches), you usually focus on:
- Independent claim scope (what is actually covered)
- Priority/filing dates and whether claims are early “preclinical” coverage vs later formulation/combination claims
- Whether claims specify abemaciclib precisely or cover a broader genus
- Whether the patent has lapsed, been narrowed, or is litigated (this is common for high-value oncology drugs)
Again, I can’t answer those points without the Google Patents page content.
What I need from you to answer accurately
Send one of the following, and I’ll produce a precise abemaciclib-focused explanation:
- The Google Patents URL for US20100160340A1, or
- The patent title + abstract, or
- Claim 1 text (or a screenshot you paste as text)
Sources
None yet.